November 08, 2020

Findings Reflect the Company’s Global Leadership Across
Multiple Facets of Ocular and Clinical Science

SAN RAMON, Calif., November 8, 2020—Beginning today, attendees at the 2020 BCLA UK Virtual Conference and Exhibition can learn more about some of the latest research in eye health as part of the meeting’s scientific program. Among those advancements are several CooperVision-affiliated papers and posters, which reflect the company’s global leadership in multiple facets of ocular and clinical science.

“At a time when eye care professionals (ECPs) are being inundated by new products and marketing claims, we want to ensure that sound science continues to be central to clinical decisions,” said Anna Sulley, BSc(Hons), MCOptom, FAAO, FBCLA, Director, Global Medical Affairs for CooperVision. “Our scientific presentations focus on inventive products currently available, novel concepts that may give rise to future developments, and attitudes and behaviors among ECPs and consumers that have industry-wide impacts.”

The papers and posters were originally planned to be shared at the 2020 Dutch Contact Lens Congress (NCC). With that event’s postponement to 2022, BCLA offered authors the opportunity to present their work as part of this week’s virtual gathering. The research can be viewed at

Addressing the Global Myopia Epidemic

Addressing the global myopia epidemic1, CooperVision and CooperVision Specialty EyeCare is disseminating research findings specific to the issue. These include analysis of opportunities to increase parental and ECP understanding of the disease, proven myopia management outcomes with the MiSight® 1 day contact lens, and myopia management advancements using orthokeratology:

  • Efficacy of software-based fitting in orthokeratology. Beerten R et al. paper presentation.
  • Parent attitudes to myopia and its management. Lumb E et al. poster presentation.
  • Global survey on eye care practitioner perceptions and attitudes to myopia and its management. Sulley A et al. poster presentation.
  • Evaluation of children in the Netherlands fitted with a dual focus 1 day contact lens. Steenbekkers G. paper presentation.
  • Visual acuity, vision performance acceptability and over-refraction in myopic children wearing dual-focus contact lenses. Logan N et al. paper presentation.
  • Five years of daily disposable contact lens wear in children. Woods J et al. paper presentation.

Improving the Contact Lens Wear Experience

Looking at broader opportunities and challenges, CooperVision scientists and research partners are speaking to developing technology solutions to guide ECPs in making the right contact lens selection to help enhance patient satisfaction. They are also lecturing on developments in silicone hydrogel lens design and manufacturing that underpin brand preference and wearing experiences. In addition, the company is sharing studies that identify behaviors and attitudes among new contact lens wearers that can help counteract the dropout conundrum for the good of the entire profession, plus COVID-19-driven behaviors. These presentations include:

  • Global Contact Lens Wear and Purchase Behavior Before, During and After COVID-19. A Sulley et al. poster presentation.
  • Satisfaction of habitual wearers of reusable multifocal lenses when refit with a daily disposable, silicone hydrogel multifocal lens. Woods J et al. poster presentation.
  • Qualitative research to understand patient experience during contact lens teaching and aftercare, and how to optimize experience to help retain wearers. Bogers A et al. paper presentation.
  • Contact lens trial conversion in a UK survey: the dynamic between those who try and those who buy. McParland M et al. paper presentation.
  • ECP Drivers for and New Wearer Attitudes on 1 Day Silicone Hydrogel Lenses in Italy. G Orsborn et al. poster presentation.
  • Association between subjective ratings and overall lens acceptance in daily disposable contact lens wear. Vega J et al. paper presentation.
  • New and habitual wearer experience with a silicone hydrogel reusable multifocal contact lens in France. McParland M et al. poster presentation.
  • Toric lens fitting success supported by an online fitting app. Luensmann D et al. paper presentation.
  • The use of a modern web-application to assist reusable toric lens fitting success. Luensmann D et al. paper presentation.

In response to the ongoing COVID-19 pandemic, the 2020 BCLA UK transitioned to a fully virtual event. Delegates from the UK and overseas can attend the conference and exhibition online, with both the main digital seminar lecture track and workshop track available via live streaming.

# # #

1 Holden et al, - Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit

Media Contact
Mike McDougall, APR, Fellow PRSA, McDougall Communications or +1-585-434-2150